🔥🐔 BizChicken 🐔🔥
Companies Similar to Molecular Templates, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CytomX Therapeutics, Inc.
Probody technology platform
Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.
Symbol: CTMX
Recent Price: $1.02
Industry: Biotechnology
CEO: Dr. Sean A. McCarthy DPHIL
Sector: Healthcare
Employees: 120
Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 515 3185
Last updated: 2024-12-31
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Molecular Templates, Inc.
ETB Drug Platform
Molecular Templates, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform.
Symbol: MTEM
Recent Price: $0.05
Industry: Biotechnology
CEO: Dr. Eric E. Poma Ph.D.
Sector: Healthcare
Employees: 62
Address: 9301 Amberglen Boulevard, Austin, TX 78729
Phone: 512 869 1555
Leadership
- Eric Poma, Ph.D., Chief Executive Officer & Chief Scientific Officer
- Jason Kim, President & Chief Financial Officer
- Kristen Quigley, Chief Operating Officer
- Grace Kim, Chief Strategy Officer & Head of Investor Relations
- Michelle Iwamoto-Fan, Ph.D., J.D., Senior Vice President and General Counsel
- Chris Moore, Ph.D., Senior Vice President and Head of Preclinical Development and Translational Medicine
- Joseph Phillips, Ph.D., Senior Vice President and Head of CMC Development
- Harold E. “Barry” Selick, Ph.D., Chairman of the Board
- David R. Hoffmann, Director
- Kevin M. Lalande, Founding Managing Director and Chief Investment Officer of Santé
- Gabriela Gruia, M.D., Director
- Corsee Sanders, Ph.D., Director
Last updated: 2024-12-31
OmniAb, Inc.
Omni Ab platform
Omni Ab, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's platform leverages transgenic animals to generate human-like antibodies for therapeutic applications.
Symbol: OABI
Recent Price: $3.56
Industry: Biotechnology
CEO: Mr. Matthew W. Foehr
Sector: Healthcare
Employees: 106
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 510 250 7800
Leadership
- Matt Foehr, Chief Executive Officer
- Kurt Gustafson, Chief Financial Officer
- Charles Berkman, JD, Chief Legal Officer and Secretary
- Yasmina Abdiche, PhD, Vice President, Exploratory Research
- Laurel Bernstein, PhD, Vice President, Intellectual Property
- Neil Castle, PhD, Vice President, Biology
- Bob Chen, PhD, Sr. Director, Discovery Systems
- Ellen Collarini, PhD, Sr. Director, Cell Biology
- Bill Harriman, PhD, Sr. Vice President, Antibody Discovery
- Christel Iffland, PhD, Sr. Vice President, Antibody Technologies
- Shelley Izquierdo, PhD, Sr. Director, Antibody Discovery
- Doug Krafte, PhD, Site Head – Durham, North Carolina Sr. Vice President, Ion Channels/Transporters
- Phil Leighton, PhD, Fellow
- Cia McCaffrey, Vice President, People and Talent
- Anil Nair, PhD, Vice President, In Silico Discovery
- Todd Pettingill, CFA, Vice President, Business Development and Strategy
- Chris Silvia, PhD, Vice President, Data Sciences and Corporate IT
- Eric Vajda, PhD, Vice President, Preclinical R&D
- Marie-Cecile van de Lavoir, DVM, PhD, Sr. Vice President, Technical Operations and Genetics
- Donna Ventura, CPA, Sr. Vice President, Corporate Controller
- Carolyn R. Bertozzi, PhD, Board Member
- Sarah Boyce, President and Chief Executive Officer
- Jennifer Cochran, PhD, Board Member
- Matthew W. Foehr, President and Chief Executive Officer
- John Higgins, Board Chair
- Steve Love, Chief Financial Officer
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Biomea Fusion, Inc.
BMF-219
Biomea Fusion, Inc. is a biopharmaceutical company specializing in the discovery and development of covalent small molecule drugs for patients with genetically defined cancers and metabolic diseases. Their lead product candidate, BMF-219, targets multiple cancers.
Symbol: BMEA
Recent Price: $3.88
Industry: Biotechnology
CEO: Mr. Thomas Andrew Butler
Sector: Healthcare
Employees: 107
Address: 900 Middlefield Road, Redwood City, CA 94063
Phone: 650 980 9099
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
biote Corp.
Biote platform
biote Corp. operates in the hormone optimization space, offering a platform for Biote-certified practitioners to manage hormone imbalances and prescribe therapies. The company sells Biote-branded supplements and pellet insertion kits.
Symbol: BTMD
Recent Price: $5.91
Industry: Medical - Care Facilities
CEO: Ms. Teresa S. Weber
Sector: Healthcare
Employees: 194
Address: 1875 West Walnut Hill Lane, Irving, TX 75038
Phone: 844-604-1246
Last updated: 2024-12-31
Chimerix, Inc.
TEMBEXA (brincidofovir)
Chimerix, Inc. is a biopharmaceutical company that develops medicines to enhance the lives of patients with serious diseases, including smallpox and various tumors.
Leadership | Contact | Contact | Careers | Jobs | Jobs | About | Leadership
Symbol: CMRX
Recent Price: $3.44
Industry: Biotechnology
CEO: Mr. Michael T. Andriole M.B.A.
Sector: Healthcare
Employees: 72
Address: 2505 Meridian Parkway, Durham, NC 27713
Phone: 919 806 1074
Leadership
- Mike Andriole, President, CEO
- Joshua E. Allen, PhD, Chief Scientific Officer
- Michael A. Alrutz, JD, PhD, Senior Vice President and General Counsel
- Michelle LaSpaluto, Chief Financial Officer
- Allen Melemed, MD, MBA, Chief Medical Officer
- Tom Riga, Chief Operating and Commercial Officer
- Roy W. Ware, PhD, MBA, Chief Manufacturing Technology Officer
- Caryn Barnett, Vice President Clinical Operations
- Tom Brundage, Vice President Biostatistics
- David Jakeman, VP Accounting and Finance
- Christopher Jordan, Vice President Regulatory Affairs
- Pablo Lee, Vice President Medical Affairs
- Odin Naderer, PharmD, Vice President Clinical Pharmacology and Translational Medicine
- Mike Sherman, Chairman
- Martha J. Demski, Lead Independent Director
- Lisa Decker, PhD,
- Marc D. Kozin,
- Robert J. Meyer, MD,
- Fred A. Middleton,
- Pratik S. Multani, MD,
- Vicki Vakiener,
Last updated: 2024-12-31
Moleculin Biotech, Inc.
Annamycin
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company developing drug candidates for highly resistant tumors and viruses. Its lead product, Annamycin, is in Phase 1/2 studies, and it also works on other candidates targeting brain tumors, pancreatic cancer, and COVID-19.
Symbol: MBRX
Recent Price: $1.79
Industry: Biotechnology
CEO: Mr. Walter V. Klemp
Sector: Healthcare
Employees: 18
Address: 5300 Memorial Drive, Houston, TX 77007
Phone: 713 300 5160
Last updated: 2024-12-31
Moderna, Inc.
messenger RNA therapeutics and vaccines
Moderna, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of messenger RNA therapeutics and vaccines for various diseases including infectious diseases and cancer. It operates globally with a range of vaccines targeting respiratory, latent, and public health viruses.
Vision/Values | Contact | Careers | Careers | Careers | Careers | About | Careers | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Awards | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Careers | Careers | About | About | About | About | About | News | About
Symbol: MRNA
Recent Price: $39.38
Industry: Biotechnology
CEO: Mr. Stephane Bancel
Sector: Healthcare
Employees: 5600
Address: 200 Technology Square, Cambridge, MA 02139
Phone: 617 714 6500
Last updated: 2024-12-31
Omega Therapeutics, Inc.
OMEGA Epigenomic Programming platform
Omega Therapeutics, Inc. is a development-stage biopharmaceutical company leveraging its OMEGA Epigenomic Programming platform to utilize the power of epigenetics for therapeutic interventions across various diseases.
About | Vision/Values | Leadership | Leadership | About | Contact | Contact | About | About
Symbol: OMGA
Recent Price: $0.80
Industry: Biotechnology
CEO: Mr. Mahesh Karande
Sector: Healthcare
Employees: 93
Address: 20 Acorn Park Drive, Cambridge, MA 02140
Phone: 617 949 4360
Leadership
- Mahesh Karande, President & Chief Executive Officer
- Kaan Certel, Ph.D., Chief Business Officer
- Jennifer Nelson, Ph.D., Senior Vice President, Research
- Tony Mullin, Chief People Officer
- Barbara Chan, Senior Vice President, Finance and Chief Accounting Officer
- Lisamarie Fahy, Senior Vice President, Clinical Development Operations
- Joe Newman, Ph.D., Senior Vice President, Early Discovery
- Jeff Atkinson, Ph.D., Vice President, Technical Operations
- Eva Stroynowski, Senior Vice President, Investor Relations and Corporate Affairs
Last updated: 2024-12-31
Third Harmonic Bio, Inc.
THB001
Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing medicine for allergic and inflammatory diseases, including THB001, an oral small-molecule KIT inhibitor for treating chronic urticaria and other indications.
Symbol: THRD
Recent Price: $10.38
Industry: Biotechnology
CEO: Ms. Natalie C. Holles
Sector: Healthcare
Employees: 42
Address: 300 Technology Square, Cambridge, MA 02139
Phone: 617-915-6680
Last updated: 2024-12-31
Entrada Therapeutics, Inc.
ENTR-601-44
Entrada Therapeutics, Inc. develops endosomal escape vehicle (EEV) therapeutics for treating neuromuscular diseases, with a lead product candidate ENTR-601-44 in preclinical trials for Duchenne muscular dystrophy and myotonic dystrophy type 1.
About | Contact | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About
Symbol: TRDA
Recent Price: $17.37
Industry: Biotechnology
CEO: Mr. Dipal Doshi
Sector: Healthcare
Employees: 168
Address: 6 Tide Street, Boston, MA 02210
Phone: 857 520 9158
Last updated: 2024-12-31
XBiotech Inc.
True Human monoclonal antibodies
XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.
Symbol: XBIT
Recent Price: $4.09
Industry: Biotechnology
CEO: Mr. John Simard
Sector: Healthcare
Employees: 94
Address: 5217 Winnebago Lane, Austin, TX 78744
Phone: 512 386 2900
Last updated: 2024-12-31
Catalent, Inc.
Drug and health product solutions
Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products globally. It operates through segments like Biologics, Softgel and Oral Technologies, among others.
About | About | Leadership | About | About | DEI | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | DEI | Careers | Benefits | Careers | About | About | About | About
Symbol: CTLT
Recent Price: $63.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Alessandro Maselli
Sector: Healthcare
Employees: 17000
Address: 14 Schoolhouse Road, Somerset, NJ 08873
Phone: 732 537 6200
Last updated: 2024-12-31
AN2 Therapeutics, Inc.
epetraborole
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases, including epetraborole for non-tuberculous mycobacterial lung disease.
About | About | Contact | Contact | Careers | Careers | Careers | About | Vision/Values | Jobs | Vision/Values | Benefits | Jobs | Benefits
Symbol: ANTX
Recent Price: $1.41
Industry: Biotechnology
CEO: Mr. Eric E. Easom
Sector: Healthcare
Employees: 41
Address: 1800 El Camino Real, Menlo Park, CA 94027
Phone: 650-331-9090
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31